Serum Markers Predicting Early Non-Responsiveness to Infliximab in Rheumatoid Arthritis: Tumor Necrosis Factor (TNF)-Alpha, TNFRII, and Interleukin (IL)-17 As Potential Indicators. IRAQI JMS [Internet]. 2025 Jun. 1 [cited 2025 Jul. 5];23(1). Available from: https://iraqijms.com/index.php/jms/article/view/1177